Peter Marks, CBER director (Greg Nash/Pool via AP)

CBER's Pe­ter Marks says Covid-19 shots to mir­ror flu shots: Man­u­fac­tur­ers will be in­ter­change­able

On Jan. 26, the FDA’s vac­cines ad­comm will meet to dis­cuss the fu­ture of Covid-19 boost­er shots and vari­ant strain se­lec­tion mov­ing for­ward, and CBER Di­rec­tor Pe­ter Marks yes­ter­day pre­viewed some of what will be dis­cussed in that meet­ing.

As the bi­va­lent boost­er up­take has stalled, par­tic­u­lar­ly among chil­dren, Marks is now point­ing to ways to sim­pli­fy the process.

The VRB­PAC ad­comm won’t on­ly look at what the com­po­si­tion of these Covid-19 vac­cines should be, and what’s the tim­ing for se­lect­ing new strains, but al­so how of­ten strain se­lec­tion should take place, he said, not­ing that the FDA is “try­ing to get to some sense of nor­mal­cy for how we treat vac­ci­na­tions.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.